Platinum195mQualityChecker
Platinum-195m
Utility description: Platinum-195m
Platinum-195m Quality Checker — Platinum-195m for Theranostics and Research
ℹ️ Utility checks critical parameters of Platinum-195m:
• Radionuclidic purity (≥99.0%)
• Pt-191 and Pt-193m impurities (≤0.5% each)
• Radiochemical purity (≥95%)
• Free platinum (≤5%) — NEPHROTOXICITY!
• pH, endotoxins, sterility, heavy metals
⚠️ CRITICAL: Free platinum is highly toxic to kidneys and auditory nerve!
Impurities of other platinum isotopes degrade image quality and dosimetry.
Usage:
Platinum195mQualityChecker.exe → demo mode (console output)
Platinum195mQualityChecker.exe input.csv output.json → evaluate your data
Input format:
BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Platinum191ImpurityPercent,Platinum193mImpurityPercent,RadiochemicalPurityPercent,FreePlatinumPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType
Example (sterility: 0=sterile, 1=contaminated):
PT195M-CIS-2026-001,500.0,99.5,0.2,0.3,98.0,2.0,6.0,50.0,0,2,CisplatinAnalog
Supported product types:
• CisplatinAnalog — cisplatin analogs for distribution imaging
• FreeIon — biodistribution studies
• Nanoparticle — imaging of platinum-loaded nanoparticles
— WHY IS THIS NEEDED?
Platinum-195m (T½=4.02 days) is a promising isotope for theranostics (therapy + diagnosis):
• Emits gamma quanta (99 keV) and conversion/Auger electrons
• Allows visualization of platinum drug distribution (e.g., cisplatin) in the body
• Used for personalization of chemotherapy: if the drug does not accumulate in the tumor, treatment is futile
• Auger electrons have high LET (linear energy transfer) at short distances, promising for micrometastasis therapy
⚠️ CRITICAL:
• Radiochemical purity ≥95% — ensures platinum is in the form of the desired drug (e.g., cisplatin), not degraded forms.
• Free platinum ≤5% — IONIC PLATINUM (unbound to ligand) is extremely nephrotoxic and ototoxic. It is rapidly excreted by kidneys, damaging tubules. Control of free platinum is a patient safety issue!
• Radionuclidic purity ≥99.0% — impurities Pt-191 (T½=2.8 d) and Pt-193m (T½=4.33 d) create additional radiation background and distort quantitative imaging.
• pH 4.5–7.5 — for complex stability and blood compatibility.
• Endotoxins ≤175 EU/vial — standard for parenterals.
• Sterility — MANDATORY.
Key features:
• Specific control of platinum isotope impurities (Pt-191, Pt-193m)
• Strict control of free (ionic) platinum due to its high toxicity
• Support for various chemical forms (cisplatin analogs, nanoparticles)
• Assessment of suitability for theranostic application
Critical parameters:
• Radionuclidic purity: ≥99.0%
• Pt-191 impurity: ≤0.5%
• Pt-193m impurity: ≤0.5%
• Radiochemical purity: ≥95.0%
• Free platinum: ≤5.0% (CRITICAL!)
• pH: 4.5–7.5
• Endotoxins: ≤175 EU/vial
• Sterility: no microbial growth
• Heavy metals: ≤10 ppm
💡 Usage tips:
1. Radiochemical purity controlled by HPLC with radioactive detector.
2. Free platinum can be determined by TLC or extraction methods.
3. Platinum drugs are light and temperature sensitive; store in dark at 2-8°C.
4. Pt-195m allows SPECT imaging, although gamma energy is low (high-resolution collimator required).
5. If free platinum >5% is detected, batch is rejected due to risk of acute renal failure.
⚠️ Note: Platinum-195m is not just a diagnostic isotope, but a tool for PRECISION MEDICINE in oncology. It allows seeing whether the chemotherapy drug reaches the tumor before prescribing a toxic course. However, the toxicity of platinum itself requires strictest control of chemical form.input.csv
BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Platinum191ImpurityPercent,Platinum193mImpurityPercent,RadiochemicalPurityPercent,FreePlatinumPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType PT195M-CIS-2026-001,500.0,99.5,0.2,0.3,98.0,2.0,6.0,50.0,0,2,CisplatinAnalog PT195M-NANO-2026-002,300.0,98.5,1.0,0.5,96.0,4.0,6.5,100.0,0,5,Nanoparticle PT195M-FREE-2026-003,100.0,99.9,0.05,0.05,99.5,0.5,5.5,20.0,0,1,FreeIon
URS & FS — User Requirements and Functional Specification
This document describes the controlled interface and behaviour of Platinum195mQualityChecker for Platinum-195m.
Domain limits and critical parameters
- ℹ️ Utility checks critical parameters of Platinum-195m:
- • Radionuclidic purity (≥99.0%)
- • Pt-191 and Pt-193m impurities (≤0.5% each)
- • Radiochemical purity (≥95%)
- • Free platinum (≤5%) — NEPHROTOXICITY!
- • pH, endotoxins, sterility, heavy metals
- ⚠️ CRITICAL: Free platinum is highly toxic to kidneys and auditory nerve!
- BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Platinum191ImpurityPercent,Platinum193mImpurityPercent,RadiochemicalPurityPercent,FreePlatinumPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType
- Example (sterility: 0=sterile, 1=contaminated):
- • FreeIon — biodistribution studies
- ⚠️ CRITICAL:
- • Radiochemical purity ≥95% — ensures platinum is in the form of the desired drug (e.g., cisplatin), not degraded forms.
- • Free platinum ≤5% — IONIC PLATINUM (unbound to ligand) is extremely nephrotoxic and ototoxic. It is rapidly excreted by kidneys, damaging tubules. Control of free platinum is a patient safety issue!
- • Radionuclidic purity ≥99.0% — impurities Pt-191 (T½=2.8 d) and Pt-193m (T½=4.33 d) create additional radiation background and distort quantitative imaging.
URS — User Requirements Specification
| ID | Requirement | Criticality | Acceptance criterion |
|---|---|---|---|
| URS-001 | The utility shall accept an input.csv file with the exact headers defined in the data contract. | High | The file is processed without manual header editing. |
| URS-002 | The utility shall perform deterministic QC evaluation for Platinum-195m using input values, approved limits and domain rules. | High | Each input row receives a PASS / WARNING / FAIL status. |
| URS-003 | The utility shall validate mandatory fields, data types, numeric ranges, units and pharmaceutical/radiochemical plausibility. | High | Schema and conversion errors are explicitly reported. |
| URS-004 | The utility shall identify critical deviations related to radionuclidic purity, radiochemical purity, free radionuclide, impurities, pH, endotoxins and sterility when such fields are present. | High | A critical deviation causes FAIL or a separate critical finding. |
| URS-005 | The utility shall generate output.json with machine-readable results, source values, warnings and failures. | High | JSON is suitable for LIMS/ELN/MES integration and QA/QC review. |
| URS-006 | The utility shall not use machine learning to decide conformance. | Medium | The result is based on explicit rules, thresholds and input values. |
| URS-007 | The utility shall preserve traceability between batch number, input values, applied rules and final status. | High | The output contains the batch identifier and the list of checked parameters. |
| URS-008 | The documentation shall support IQ/OQ preparation and inspection discussion with FDA/EMA/Roszdravnadzor or local regulators. | Medium | URS & FS, input.csv/output.json contract and test scenarios are supplied with the utility. |
input.csv contract
| # | Field | Type | Sample | Purpose |
|---|---|---|---|---|
| 1 | BatchNumber | string | PT195M-CIS-2026-001 | Batch or lot identifier used for traceability. |
| 2 | TotalActivityMBq | decimal | 500.0 | Radioactivity value used for release, decay or dose-related assessment. |
| 3 | RadionuclidicPurityPercent | string | 99.5 | Radionuclidic purity; a critical radiation-safety and impurity parameter. |
| 4 | Platinum191ImpurityPercent | string | 0.2 | Controlled impurity or residual material. |
| 5 | Platinum193mImpurityPercent | string | 0.3 | Controlled impurity or residual material. |
| 6 | RadiochemicalPurityPercent | string | 98.0 | Radiochemical purity; confirms the labelled chemical form and binding quality. |
| 7 | FreePlatinumPercent | decimal | 2.0 | Free radionuclide / unbound species; important for non-target uptake and toxicity. |
| 8 | pH | decimal | 6.0 | Solution pH; relevant for stability, compatibility and administration. |
| 9 | EndotoxinsEU | decimal | 50.0 | Bacterial endotoxins; critical for parenteral administration. |
| 10 | SterilityTest | flag / boolean | 0 | Sterility result; critical release parameter. |
| 11 | HeavyMetalsPPM | decimal | 2 | Elemental impurity / metal residue parameter. |
| 12 | ProductType | string | CisplatinAnalog | Controlled input parameter used by the deterministic QC rules. |
BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Platinum191ImpurityPercent,Platinum193mImpurityPercent,RadiochemicalPurityPercent,FreePlatinumPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType PT195M-CIS-2026-001,500.0,99.5,0.2,0.3,98.0,2.0,6.0,50.0,0,2,CisplatinAnalog PT195M-NANO-2026-002,300.0,98.5,1.0,0.5,96.0,4.0,6.5,100.0,0,5,Nanoparticle PT195M-FREE-2026-003,100.0,99.9,0.05,0.05,99.5,0.5,5.5,20.0,0,1,FreeIon
FS — Functional Specification
| ID | Function | Implementation |
|---|---|---|
| FS-001 | CSV import | Read input.csv in UTF-8/CSV-compatible format and validate the header and expected columns. |
| FS-002 | Schema validation | Check mandatory fields and column count; report unknown or missing key fields. |
| FS-003 | Type conversion | Convert numeric, flag and text values; invalid formats are recorded as row-level errors. |
| FS-004 | Domain rule engine | Apply domain rules for Platinum-195m, including critical limits from the utility description and approved specification. |
| FS-005 | Status aggregation | Produce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance. |
| FS-006 | JSON export | Write output.json with detailed checks, source values, warnings, failures and critical findings. |
| FS-007 | Audit support | Keep the result structure suitable for review, deviation investigation, calculation reproduction and IQ/OQ preparation. |
| FS-008 | Integration contract | Support the production scenario: LIMS/ELN/MES creates input.csv, the utility returns output.json, the portal displays description and documentation. |
Example output.json
{
"utilityId": "platinum195m-quality-checker",
"api": "Platinum-195m",
"overallStatus": "PASS|WARNING|FAIL",
"sourceFile": "input.csv",
"checks": [
{
"parameter": "BatchNumber",
"value": "PT195M-CIS-2026-001",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "TotalActivityMBq",
"value": "500.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "RadionuclidicPurityPercent",
"value": "99.5",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Platinum191ImpurityPercent",
"value": "0.2",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Platinum193mImpurityPercent",
"value": "0.3",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "RadiochemicalPurityPercent",
"value": "98.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "FreePlatinumPercent",
"value": "2.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "pH",
"value": "6.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
}
],
"criticalFindings": []
}
OQ/PQ test scenarios
| ID | Scenario | Expected result |
|---|---|---|
| OQ-001 | Valid sample row | PASS or acceptable WARNING according to the rules. |
| OQ-002 | Mandatory column missing | Schema error or FAIL. |
| OQ-003 | Non-numeric value in numeric field | Type-conversion error. |
| OQ-004 | Critical parameter outside limit | FAIL and critical finding. |
| PQ-001 | User real batch/lot | Reviewed result with input.csv and output.json retained. |
QA/QC and change control
- Do not rename columns without updating the validator and test set.
- Retain
input.csv,output.json, executable version and checksum. - Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
- Critical radiopharmaceutical limits must be verified against the approved specification and local SOPs.
Included in packages
PetRad3: expanded PET/SPECT and radiopharmaceutical QC package
A curated suite for PET/SPECT radiopharmaceuticals, generator and cyclotron radionuclides, labelled compounds, radiochemical purity, breakthrough, sterility and endotoxin control.
OpenRadiology QC Suite
QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.
OpenRPH organ/system: oncology and theranostics
Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.
OpenRPH organ/system: renal and urinary
Renography, GFR/ERPF, renal uptake, DMSA/MAG3/DTPA and bladder-related workflows.
OpenRPH use case: generators, isotope purity and starting radionuclides
Control of generator eluate, breakthrough, radionuclidic purity, isotope mix, carrier/free radionuclides and starting radionuclides before labeling.
OpenRPH workflow: dosimetry and therapy planning
Activity planning, absorbed dose, organ dose, lung shunt, preplanning and therapy verification.
OpenRPH workflow: generators and isotope purity
Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.
OpenRPH workflow: imaging QC and quantitative interpretation
Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.
OpenRPH workflow: instruments, devices and radiation safety
PET/gamma-camera state, calibration, detector QC, energy window, TOF, shielding and radiation safety.
OpenRPH workflow: product release QC
Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.
OpenRPH workflow: stability, storage, decay and waste
Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.
OpenRPH: combined radiopharmaceutical QC package
RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.
Open